Fluralaner Chewable Tablets

Product Name: Fluralaner Chewable Tablets
Indication: For the treatment and prevention of flea and tick infestations in dogs.
A single dose provides continuous protection for up to 12 weeks.
Begins killing fleas within 2 hours, with >95% efficacy within 24 hours.
Kills Ctenocephalides felis and C. canis, and aids in the control of Flea Allergy Dermatitis (FAD).
Effective against multiple tick species, including but not limited to Ixodes ricinus, Rhipicephalus sanguineus,
Ixodes scapularis, and Amblyomma americanum.
Breaks the flea life cycle by killing adult fleas, thereby helping to control the environmental flea population.
Dosage: For oral use only.
Oral administration. Once every 12 weeks.
Select the tablet strength that most closely matches the pet’s current body weight. May be administered with or without food.

Body weight of pets (kg)	Dosage per Administration
2.<BW≤4.5	112.5mg
4.5<BW≤10.0	250mg
10.0<BW≤20.0	500mg
20.0<BW≤40.0	1000mg
40.0<BW≤56.0	1400mg
BW>56	Use a combination of pipettes

Precautions
1.This is a prescription drug and must be used under
veterinary supervision
2.Do not use in dogs under 8 weeks of age or
weighing less than 2.0 kg
3.Do not use in cats under 8 weeks of age or
weighing less than 1.2 kg
4.Use with caution in dogs with a history of seizures
or neurological disorders
5.The safety of fluralaner has not been established in
breeding, pregnant, or lactating animals
6.Keep out of reach of children

Package:
1 tablet per blister, 1 blister per box
Aluminum-plastic blister pack
Storage:
Store tightly sealed below 30°C, protected from
light and moisture
Shelf life: 2 years

Mechanism of Action
Fluralaner is a systemic insecticide and acaricide of the isoxazoline class. It inhibits gammaaminobutyric acid-gated chloride channels and Lglutamate-gated chloride channels in arthropods, leading to uncontrolled nerve activity and death of fleas and ticks. Fleas and ticks must attach to the host and commence feeding to be exposed to the active substance.

Drug Interactions
No clinically significant drug interactions have been identified
Concomitant use with other isoxazoline class parasiticides may increase the risk of neurological
adverse reactions

For animal use only.

Product Name: Fluralaner Chewable Tablets
Indication: For the treatment and prevention of flea and tick infestations in dogs.
A single dose provides continuous protection for up to 12 weeks.
Begins killing fleas within 2 hours, with >95% efficacy within 24 hours.
Kills Ctenocephalides felis and C. canis, and aids in the control of Flea Allergy Dermatitis (FAD).
Effective against multiple tick species, including but not limited to Ixodes ricinus, Rhipicephalus sanguineus, Ixodes scapularis, and Amblyomma americanum.
Breaks the flea life cycle by killing adult fleas, thereby helping to control the environmental flea population.
Dosage: For oral use only.
Oral administration. Once every 12 weeks.
Select the tablet strength that most closely matches the pet’s current body weight. May be administered with
or without food.

Body weight of pets (kg)	Dosage per Administration
2.8<BW≤6.0	112.5mg
6.0<BW≤12.0	250mg
12.0<BW≤24.0	500mg
24.0<BW≤48.0	1000mg
48.0<BW≤56.0	1400mg

Withdrawal:
Not applicable
Package:
30 tablets per bottle
Storage:
Store tightly sealed below 25℃
Shelf life: 2 years
Warning：
This product contains a highconcentration, last-resort antibiotic.
Accidental ingestion by humans may cause serious health effects and contribute to antibiotic resistance. Seek medical advice immediately if ingested.

Important Notes
(1)Prescription-only: This is a prescription-only medicine. Administration MUST be under the direct supervision and guidance of a veterinarian.
(2)Complete the Course: Even if symptoms improve, administer the full course as prescribed to prevent relapse and resistance development.
(3)Monitoring: Regular monitoring of renal function and overall clinical response is essential during treatment.
(4)Adverse Reactions: Potential side effects may include vomiting, diarrhea, loss of appetite, or in rare cases neurological signs (e.g., tremors). Discontinue use and contact your veterinarian immediately if adverse reactions occur.
(5)THERAPEUTIC WARNING: While this product is a specific antiviral agent, the successful management of feline panleukopenia critically depends on timely and aggressive supportive care to address dehydration, secondary infections, and nutritional support. This product does not replace essential fluid and electrolyte therapy.

For animal use only.